Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4630)
All Articles published online
|
Publishing Process of This Article
|
Jan 26, 2014 (publication date) through Jun 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Letonja M, Petrovič D. Is diabetic cardiomyopathy a specific entity? World J Cardiol 2014; 6(1): 8-13 [PMID: 24527183 DOI: 10.4330/wjc.v6.i1.8] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v6/i1/8.htm |
| Number | Citing Articles |
| 1 |
Edgar Argulian, Partho P. Sengupta. Speckle Tracking Echocardiographic Imaging in Metabolic Cardiomyopathies. Current Cardiovascular Imaging Reports 2016; 9(10) doi: 10.1007/s12410-016-9390-0
|
| 2 |
Adam L. Burrack, Tijana Martinov, Brian T. Fife. T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes. Frontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00343
|
| 3 |
Tao Bai, Fan Wang, Nicholas Mellen, Yang Zheng, Lu Cai. Diabetic cardiomyopathy: role of the E3 ubiquitin ligase. American Journal of Physiology-Endocrinology and Metabolism 2016; 310(7): E473 doi: 10.1152/ajpendo.00467.2015
|
| 4 |
Anne Ringle, Anne Dornhorst, Michaela B Rehman, Cristina Ruisanchez, Petros Nihoyannopoulos. Evolution of subclinical myocardial dysfunction detected by two-dimensional and three-dimensional speckle tracking in asymptomatic type 1 diabetic patients: a long‑term follow-up study. Echo Research and Practice 2017; 4(4): 73 doi: 10.1530/ERP-17-0052
|
| 5 |
Li Deng, Xuxin Chen, Yi Zhong, Xing Wen, Ying Cai, Jiafu Li, Zhongcai Fan, Jian Feng. Activation of TGR5 Partially Alleviates High Glucose-Induced Cardiomyocyte Injury by Inhibition of Inflammatory Responses and Oxidative Stress. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/6372786
|
| 6 |
Bernard Kianu Phanzu, Aliocha Nkodila Natuhoyila, Eleuthère Kintoki Vita, Jean-René M’Buyamba Kabangu, Benjamin Longo-Mbenza. Association between insulin resistance and left ventricular hypertrophy in asymptomatic, Black, sub-Saharan African, hypertensive patients: a case–control study. BMC Cardiovascular Disorders 2021; 21(1) doi: 10.1186/s12872-020-01829-y
|
| 7 |
Jean-Paul Bounhoure, Michel Komajda. Cardiomyopathie Diabétique: une entité spécifique?. Bulletin de l'Académie Nationale de Médecine 2017; 201(1-3): 325 doi: 10.1016/S0001-4079(19)30528-X
|
| 8 |
Alicia J. Jenkins, David N. O’Neal, Christopher J. Nolan, Andrzej S. Januszewski. Pancreatic Islet Biology. Stem Cell Biology and Regenerative Medicine 2016; : 1 doi: 10.1007/978-3-319-45307-1_1
|
| 9 |
Ronghui Han, Hemeng Huang, Weiyi Xia, Jingjin Liu, Hui Luo, Jing Tang, Zhengyuan Xia. Perspectives for Forkhead box transcription factors in diabetic cardiomyopathy: Their therapeutic potential and possible effects of salvianolic acids. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.951597
|
| 10 |
Satish K. Raut, Gurinder B. Singh, Bhawna Rastogi, Uma Nahar Saikia, Anupam Mittal, Nilambra Dogra, Sandeep Singh, Rishikesh Prasad, Madhu Khullar. miR-30c and miR-181a synergistically modulate p53–p21 pathway in diabetes induced cardiac hypertrophy. Molecular and Cellular Biochemistry 2016; 417(1-2): 191 doi: 10.1007/s11010-016-2729-7
|
| 11 |
L. Ernande. Diabète et insuffisance cardiaque : la cardiomyopathie diabétique. Médecine des Maladies Métaboliques 2015; 9(4): 377 doi: 10.1016/S1957-2557(15)30138-3
|